Screener/Sentinel Bio

Sentinel Bio

Nonprofit philanthropic fund deploying $15M/year to mitigate AI-enabled biosecurity risks and strengthen nucleic acid synthesis governance.

HQ🇺🇸 US
Est2024
Size11-50
sentinelbio.org
Score
62.0 / 100
Evidence
7 items
Confidence
medium

Strong safety posture with established governance frameworks and active risk management.

Strengths:Governance Maturity, Technical Safety, Risk Assessment, Regulatory Readiness, External Engagement
Focus Areas
biosecurityai biosafetysynthesis screeningpandemic preventiondual-use risk

Strengths

  • Strong social impact assessment
  • Risk score (72) indicates strong practices

Risks

No significant risks identified

Table of Contents

Security Assessment

Security-relevant indicators for vendor evaluation

Security Posture
64
TS-01dim: 55
Red Teaming & Pre-deployment Testing
Adversarial testing before deployment
TS-05dim: 55
Robustness & Adversarial Resilience
Resistance to adversarial attacks
RA-01dim: 72
Sector-Specific Risk Assessment
Risk analysis for deployment context
RA-03dim: 72
Dual-Use & Misuse Risk
Dangerous capability awareness
RA-07dim: 72
Incident History & Track Record
Past incidents and response quality
EE-04dim: 65
Vulnerability Disclosure Program
Bug bounty or CVE reporting process
Incident History
Sentinel Bio incident records sourced from AIAAIC Repository and public reporting.
Integration: AIAAIC, OECD AI Incidents Monitor
Third-Party Audits
External audit reports, SOC 2 attestations, and ISO certifications verified where published.
Sources: Company filings, registry lookups
CVE & Disclosures
Known vulnerabilities and security advisories from NVD, GitHub Security Advisories, and vendor pages.
Sources: NVD, GHSA, vendor disclosure pages

Dimension Breakdown

GM
Governance Maturitypreliminary
Published policies, corporate structure, safety mandate, whistleblowing, executive commitment.
68
TS
Technical Safetypreliminary
Benchmarks, adversarial robustness, fine-tuning safety, watermarking, model cards, research output.
55
RA
Risk Assessmentpreliminary
Dangerous capability evaluations, thresholds, external testing, bug bounty, halt conditions.
72
RR
Regulatory Readinesspreliminary
ISO 42001, EU AI Act compliance, GPAI obligations, international commitments, incident reporting.
50
EE
External Engagementpreliminary
Survey participation, research support, transparency, behavior specs, open-source contributions.
65

Social Impact & Safety Profile

Strong

Sentinel Bio researches, funds, and scales solutions to prevent AI-enabled biosecurity threats. Their two pillars: safeguarding powerful biological AI models and improving governance of synthetic nucleic acids. An independent study they reference found early-2025 AI models outperformed 94% of human virologists, with only 3% of biological design tools having safety measures. Led by CEO Claire Qureshi (15+ years biotech/global health). Raised $10M+ in discretionary capital, advised on $4M in external grants, expects to deploy up to $15M/year by 2026. Supported by Hewlett Foundation, AI Safety Tactical Opportunities Fund, and others.

ai biosecuritysynthesis screeningpandemic preventiondual-use governance

Peer Comparison

AI Underwriting Company
A-70

Governance Tooling

Compare
Gray Swan
B+64.7

Evaluations & Benchmarking

Compare
Haize Labs
B56.7

Evaluations & Benchmarking

Compare
Red Queen Bio
C43

Biosafety & Agentic AI

Compare
Compare side-by-side →

Data Sources & Methodology

Scoring methodology v0.1 · 40 indicators · 6 frameworks

Last assessment: 2026-04-03 · Confidence: medium · Evidence: 7 items

NIST AI RMF · EU AI Act · ISO 42001 · FLI AI Safety Index · MLCommons AILuminate · METR

How is this company scored? →Full methodologyView in Screener

Scores reflect publicly available information. A low score may indicate limited transparency rather than poor safety practices.